Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Meropenem plus Pralurbactam for hospital-acquired pneumonia and ventilator-associated pneumonia is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hospital-acquired Pneumonia
• Ventilator-associated Pneumonia

Drugs mentioned

• Meropenem (Meropenem)
• Pralurbactam (Pralurbactam)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia | Phase 3 | Status: RECRUITING